Cardica, Inc. (CRDC) is a medical device company that develops and commercializes automated anastomosis systems to facilitate coronary artery bypass graft (CABG) surgeries. The company's products are designed to enable rapid and reliable joining of blood vessels and other tubular structures. Its flagship product, the C-Port Distal Anastomosis System, is used in CABG surgeries to create a secure connection between the bypass graft and the coronary artery. Cardica was founded in 1997 and is headquartered in Redwood City, California. However, the company announced in 2017 that it had ceased operations and was in the process of liquidating its assets.
Cardica, Inc. (CRDC) is a medical device company that develops and commercializes automated anastomosis systems to facilitate coronary artery bypass graft (CABG) surgeries. The company's products are designed to enable rapid and reliable joining of blood vessels and other tubular structures. Its flagship product, the C-Port Distal Anastomosis System, is used in CABG surgeries to create a secure connection between the bypass graft and the coronary artery. Cardica was founded in 1997 and is headquartered in Redwood City, California. However, the company announced in 2017 that it had ceased operations and was in the process of liquidating its assets.